CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

导出原文传递

翻译打印收藏纠错

作者： Alex D. Michaels ^[1] ; Timothy E. Newhook ^[2] ; Sara J. Adair ^[3] ; Sho Morioka ; Bernadette J. Goudreau ; Sarbajeet Nagdas ; Matthew G. Mullen ; Jesse B. Persily ; Timothy N. J. Bullock ; Craig L. Slingluff ; Kodi S. Ravichandran ; J. Thomas Parsons ; Todd W. Bauer

作者单位： Department of Pathology, University of Virginia Health System, Charlottesville, Virginia. ^[1] Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System ^[2] Department of Surgery, University of Virginia Health System, Charlottesville, Virginia. ^[3]

发布时间 2019-04-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Clinical cancer research

2018年24卷6期

1415-1425页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除